Abdominal exploration for suspected recurrent carcinoma of the colon and rectum based upon elevated carcinoembryonic antigen alone or in combination with other diagnostic methods
- PMID: 3704903
Abdominal exploration for suspected recurrent carcinoma of the colon and rectum based upon elevated carcinoembryonic antigen alone or in combination with other diagnostic methods
Abstract
Thirty-six patients underwent abdominal exploration due to elevated carcinoembryonic antigen (CEA) levels after a curative resection for carcinoma of the colon and rectum. Three groups were evaluated. In group 1, CEA elevation alone was the indication for the exploration in 13 asymptomatic patients. In group 2, 13 other asymptomatic patients underwent exploration because of elevated CEA levels in combination with other findings. In group 3, ten patients were symptomatic with an elevated CEA level at the time of exploration. Five patients from groups 1 and 2 underwent a curative resection for recurrent tumor (14 per cent). Three of these patients are still alive more than five years after exploration. Nine patients had negative findings at exploration for tumor recurrence (25 per cent false-positive results). Six of these patients are alive while three have died of metastatic disease. Twenty-two of the 36 patients (61 per cent) had unresectable disease at the time of exploration. Four of these patients underwent some form of surgical palliative procedure. Considering the five patients who underwent a curative resection with the latter four patients, this results in 25 per cent of the patients benefitting from surgical exploration.
Similar articles
-
Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum.Acta Chir Scand. 1982;148(2):189-93. Acta Chir Scand. 1982. PMID: 7148317
-
Surveillance strategies after resection of carcinoma of the colon and rectum.Surg Gynecol Obstet. 1990 Sep;171(3):267-73. Surg Gynecol Obstet. 1990. PMID: 2201097 Review.
-
Postoperative surveillance of patients with carcinoma of the colon and rectum.Am Surg. 1990 Jan;56(1):22-7. Am Surg. 1990. PMID: 2294807
-
Prospective monitoring trial for carcinoma of colon and rectum after surgical resection.Surg Gynecol Obstet. 1989 Dec;169(6):479-87. Surg Gynecol Obstet. 1989. PMID: 2683153
-
Carcinoembryonic antigen in patients with breast or colon cancer.West J Med. 1978 Nov;129(5):374-80. West J Med. 1978. PMID: 364839 Free PMC article. Review.
Cited by
-
Tumor angiogenesis predicts recurrence with normal serum carcinoembryonic antigen in advanced rectal carcinoma patients.Surg Today. 1999;29(10):983-91. doi: 10.1007/s005950050633. Surg Today. 1999. PMID: 10554319
-
The use and potential of serum tumour markers, new and old.Drugs. 1989 Jul;38(1):9-18. doi: 10.2165/00003495-198938010-00002. Drugs. 1989. PMID: 2670513 Review. No abstract available.
-
Cost-effective management of colon and rectal cancer.World J Surg. 1991 Sep-Oct;15(5):597-604. doi: 10.1007/BF01789205. World J Surg. 1991. PMID: 1949858 Review.